MATTHEW KYER: Open Payments
NPI 1003989799 · ROCK HILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 13 payments from 8 companies in 2025. Trend: 2023 $282 · 2024 $183 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $86 |
| ABBVIE INC. | 3 | $78 |
| PFIZER INC. | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
Products named: DUPIXENT, UBRELVY, NURTEC ODT, KEYTRUDA, TEZSPIRE, Symbravo, XHANCE.
Industry payments across SC — which companies pay providers there.
